Week of November 29 - December 5, 2015
Osimertinib (Tagrisso™)Osimertinib (Tagrisso™) is a kinase inhibitor indicated for the treatment of metastatic epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer.
Surgical Procedures: OophorectomyAn oophorectomy is a surgical procedure that is done alone or in combination with another procedure, such as a hysterectomy, to remove the ovaries.
Surgical Procedures: HysterectomyA hysterectomy is a surgical procedure that is done to remove the uterus and is often used in cancer treatments.
Cobimetinib (Cotellic™)Cobimetinib (Cotellic™) is a kinase inhibitor indicated for the treatment of patients with melanoma with a BRAF V600E or V600K mutation.
Trabectedin (Yondelis®)Trabectedin (Yondelis®) is a chemotherapy used in the treatment of unresectable or metastatic liposarcoma or leiomyosarcoma.
Surgical Treatments: VulvectomyA vulvectomy is a procedure in which a surgeon removes all or part of the vulva, most often for the treatment of vulvar cancer.
Irinotecan Liposome (Onivyde™)New chemotherapy medication indicated in the treatment of metastatic pancreatic cancer.
DSRT: Getting StartedThis short video tutorial is based on a presentation given at the Association of Oncology Social Workers (AOSW) Annual Conference. It is a quick introduction to the tool and how to use it in practice.
OncoLink eNews November 2015Receive cutting-edge information from some of the foremost cancer authorities from the University of Pennsylvania, delivered to your email.
KeywordsClick on any of these terms for more related articles
September 05, 2014
November 25, 2015